The Pennant Group/$PNTG
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About The Pennant Group
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
- Ticker
- $PNTG
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 9,700
- Headquarters
- Eagle, United States
- Website
- pennantgroup.com
PNTG Metrics
BasicAdvanced
$1.5B
45.76
$0.91
1.29
-
Price and volume
Market cap
$1.5B
Beta
1.29
52-week high
$43.41
52-week low
$22.26
Average daily volume
316K
Financial strength
Current ratio
1.205
Quick ratio
0.974
Long term debt to equity
1.131
Total debt to equity
1.225
Interest coverage (TTM)
6.03%
Profitability
EBITDA (TTM)
74.57
Gross margin (TTM)
19.59%
Net profit margin (TTM)
2.93%
Operating margin (TTM)
5.85%
Effective tax rate (TTM)
26.89%
Revenue per employee (TTM)
$110,000
Management effectiveness
Return on assets (TTM)
4.50%
Return on equity (TTM)
10.42%
Valuation
Price to earnings (TTM)
45.755
Price to revenue (TTM)
1.312
Price to book
4.07
Price to tangible book (TTM)
-19.24
Price to free cash flow (TTM)
55.456
Free cash flow yield (TTM)
1.80%
Free cash flow per share (TTM)
0.751
Growth
Revenue change (TTM)
37.90%
Earnings per share change (TTM)
17.96%
3-year revenue growth (CAGR)
29.97%
3-year earnings per share growth (CAGR)
29.83%
What the Analysts think about PNTG
Analyst ratings (Buy, Hold, Sell) for The Pennant Group stock.
Analyst projections of the future price of The Pennant Group stock.
Bulls say / Bears say
Second-quarter revenue rose 35.8% and adjusted EBITDA increased 48.2%; Pennant also raised its 2026 outlook after saying the Southeast acquisition integration was progressing ahead of expectations. (SEC)
Growth is not just coming from acquisitions: same-store home health admissions rose 9.7% in the second quarter, showing continued demand across Pennant’s existing agencies. (SEC)
Senior living’s same-store occupancy rose 150 basis points and revenue per occupied room increased 5.5% year on year in the second quarter, supporting the case for stronger returns from its existing communities. (McKnight's Senior Living)
Pennant is exposed to shifts in public reimbursement: Medicare and Medicaid accounted for 64.3% of second-quarter revenue, and the company cited a 1.3% home health reimbursement cut as a first-quarter headwind. (SEC, GlobeNewswire)
A six-month federal enrolment moratorium has delayed four planned home health and hospice start-ups, limiting Pennant’s ability to expand organically in some underserved markets. (Hospice News)
Recently acquired senior living communities have low occupancy, and management expects margin performance to be uneven in the third and fourth quarters as it integrates them. (McKnight's Senior Living)
Data summarised monthly by Lightyear AI. Last updated on 15 Oct 2026.
PNTG Financial Performance
Revenues and expenses
PNTG Earnings Performance
Company profitability
Upcoming events
No upcoming events
PNTG News
AllArticlesVideos
Funds containing PNTG
Fund name | Fund size | $PNTG weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.12% |
iShares Ageing Population€AGED | $903M | 0.12% |
iShares Ageing Population£AGES | $953M | 0.12% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $3.2B | 0.06% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $3.2B | 0.06% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.